Blake Bruneman
YOU?
Author Swipe
View article: F-76 | C-Reactive Protein and Clinical Outcomes of Endovascular Intervention in Patients with Symptomatic Peripheral Artery Disease From The XLPAD Registry
F-76 | C-Reactive Protein and Clinical Outcomes of Endovascular Intervention in Patients with Symptomatic Peripheral Artery Disease From The XLPAD Registry Open
View article: F-59 | Clinical Outcomes and Patient Perceived Symptoms Comparing Iso-Osmolar and Hypo-Osmolar Contrast Agents Used During Lower Extremity Peripheral Artery Endovascular Intervention
F-59 | Clinical Outcomes and Patient Perceived Symptoms Comparing Iso-Osmolar and Hypo-Osmolar Contrast Agents Used During Lower Extremity Peripheral Artery Endovascular Intervention Open
View article: F-72 | Duration of Dual Anti-Platelet Therapy and Major Adverse Limb Outcomes of Endovascular Intervention for Symptomatic Peripheral Artery Disease from The XLPAD Registry
F-72 | Duration of Dual Anti-Platelet Therapy and Major Adverse Limb Outcomes of Endovascular Intervention for Symptomatic Peripheral Artery Disease from The XLPAD Registry Open
View article: OR9-3 | Endovascular Outcomes of Patients with Heart Failure Undergoing Non-Stent Infrainguinal Interventions from the XLPAD Registry
OR9-3 | Endovascular Outcomes of Patients with Heart Failure Undergoing Non-Stent Infrainguinal Interventions from the XLPAD Registry Open
There are limited data comparing endovascular intervention outcomes in heart failure (HF) patients presenting with symptomatic peripheral artery disease (PAD). Herein we report comparative outcomes (peri-procedural and 1-year major adverse…